SAB Biotherapeutics Highlights Diabetes Trial Progress, Human Antibody PlatformMarketBeat · 3 days ago
Orchestra BioMed to Host R&D Day Featuring Clinical Insights and Development Plans for AVIM Therapy and Virtue® SABGlobeNewsWire · 3 days ago
SAB BIO to Participate in Chardan 10th Annual Healthcare ConferenceGlobeNewsWire · Oct 14, 2026
SAB BIO Receives FDA Fast Track Designation for SAB-142 in Stage 3 Type 1 DiabetesGlobeNewsWire · Oct 13, 2026
SAB BIO to Present SAB-142 Data at the Inaugural Breakthrough T1D Clinical & Research CongressGlobeNewsWire · Oct 1, 2026
SAB BIO to Present SAB-142 Data at the 62nd Annual Meeting of the European Association for the Study of DiabetesGlobeNewsWire · Sep 22, 2026Saratoga Investment Corp. offers capital solutions to mid-sized businesses, encompassing both loan facilities and direct equity investments.